1427393-40-5 Usage
Uses
Used in Organic Synthesis:
1-chloro-7-methoxyisoquinoline-6-carbonitrile is used as a building block in organic synthesis for the preparation of various pharmaceutical and agrochemical compounds. Its unique structure allows for the formation of diverse chemical entities with potential therapeutic and agricultural applications.
Used in Medicinal Chemistry:
1-chloro-7-methoxyisoquinoline-6-carbonitrile is used as a starting material in medicinal chemistry for the development of new drugs. Its chemical properties and biological activities make it a valuable compound for the synthesis of potential therapeutic agents.
Used in Anticancer Research:
1-chloro-7-methoxyisoquinoline-6-carbonitrile is used as an anticancer agent in research studies. Its potential biological activities have been investigated for their ability to target and inhibit the growth of cancer cells, making it a promising candidate for the development of novel cancer therapies.
Used in Antimicrobial Research:
1-chloro-7-methoxyisoquinoline-6-carbonitrile is used as an antimicrobial agent in research studies. Its potential to inhibit the growth of microorganisms, such as bacteria and fungi, has been explored, making it a candidate for the development of new antimicrobial drugs to combat drug-resistant infections.
Check Digit Verification of cas no
The CAS Registry Mumber 1427393-40-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,2,7,3,9 and 3 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1427393-40:
(9*1)+(8*4)+(7*2)+(6*7)+(5*3)+(4*9)+(3*3)+(2*4)+(1*0)=165
165 % 10 = 5
So 1427393-40-5 is a valid CAS Registry Number.
1427393-40-5Relevant articles and documents
IRAK DEGRADERS AND USES THEREOF
-
, (2020/06/19)
The present invention provides compounds, compositions thereof, and methods of using the same.
IRAK DEGRADERS AND USES THEREOF
-
, (2021/01/23)
The present invention provides compounds, compositions thereof, and methods of using the same. The compounds include an IRAK binding moiety and a degradation inducing moiety (DIM). The DIM could be DTM a ligase binding moiety (LBM) or lysine mimetic. The compounds could be useful as IRAK protein kinase inhibitors and applied to IRAK mediated disorders.
IRAK DEGRADERS AND USES THEREOF
-
, (2019/07/10)
The present invention provides compounds, compositions thereof, and methods of using the same.
Bicyclic-Fused Heteroaryl or Aryl Compounds
-
, (2015/10/28)
Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia, as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
